← Globant SA overview

Globant SA vs UBTECH Robotics: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Globant SA (GLOB)

Q3 2026
▼2▲1

Globant cuts 2026 outlook as demand weakens, AI growth offers hope

  • Full-year guidance cut and Q2 EPS miss Globant cut its 2026 revenue, margin, and EPS outlook and missed non-GAAP EPS by $0.10, blaming weaker demand in new markets, oil-price pressure on travel clients, and slow client decisions. The stock fell about 13-15%, as lower profit expectations directly reduce what investors will pay for shares.

    This is the main new event that moved the stock and reset expectations for the year.

  • Glob.AI output-based pricing launch and 60% ARR jump Globant launched Glob.AI, an AI platform billed by output rather than hours, and said its Glob AI annual recurring revenue jumped about 60% to $52.8 million, targeting over $110 million by year-end. This supports the long-term story that AI services can grow faster and earn better margins, though it is not yet big enough to offset the guidance cut.

    It is the main new positive force and the company's key growth narrative.

  • Securities class action over Latin America disclosures A securities class action alleges Globant misled investors about its Latin American operations, which were said to face declining demand, client defections, and frozen wages. The June 23 lead-plaintiff deadline passed, but the lawsuit remains an overhang, adding legal costs and uncertainty that can weigh on the stock.

    It is a new legal risk that can affect investor confidence and costs.

July 2026
▼2▲1

Globant cuts 2026 outlook as demand weakens, AI growth offers hope

  • Full-year guidance cut and Q2 EPS miss Globant cut its 2026 revenue, margin, and EPS outlook and missed non-GAAP EPS by $0.10, blaming weaker demand in new markets, oil-price pressure on travel clients, and slow client decisions. The stock fell about 13-15%, as lower profit expectations directly reduce what investors will pay for shares.

    This is the main new event that moved the stock and reset expectations for the year.

  • Glob.AI output-based pricing launch and 60% ARR jump Globant launched Glob.AI, an AI platform billed by output rather than hours, and said its Glob AI annual recurring revenue jumped about 60% to $52.8 million, targeting over $110 million by year-end. This supports the long-term story that AI services can grow faster and earn better margins, though it is not yet big enough to offset the guidance cut.

    It is the main new positive force and the company's key growth narrative.

  • Securities class action over Latin America disclosures A securities class action alleges Globant misled investors about its Latin American operations, which were said to face declining demand, client defections, and frozen wages. The June 23 lead-plaintiff deadline passed, but the lawsuit remains an overhang, adding legal costs and uncertainty that can weigh on the stock.

    It is a new legal risk that can affect investor confidence and costs.

Latest
▼2▲1

Globant cuts 2026 outlook as demand weakens, AI growth offers hope

  • Full-year guidance cut and Q2 EPS miss Globant cut its 2026 revenue, margin, and EPS outlook and missed non-GAAP EPS by $0.10, blaming weaker demand in new markets, oil-price pressure on travel clients, and slow client decisions. The stock fell about 13-15%, as lower profit expectations directly reduce what investors will pay for shares.

    This is the main new event that moved the stock and reset expectations for the year.

  • Glob.AI output-based pricing launch and 60% ARR jump Globant launched Glob.AI, an AI platform billed by output rather than hours, and said its Glob AI annual recurring revenue jumped about 60% to $52.8 million, targeting over $110 million by year-end. This supports the long-term story that AI services can grow faster and earn better margins, though it is not yet big enough to offset the guidance cut.

    It is the main new positive force and the company's key growth narrative.

  • Securities class action over Latin America disclosures A securities class action alleges Globant misled investors about its Latin American operations, which were said to face declining demand, client defections, and frozen wages. The June 23 lead-plaintiff deadline passed, but the lawsuit remains an overhang, adding legal costs and uncertainty that can weigh on the stock.

    It is a new legal risk that can affect investor confidence and costs.

UBTECH Robotics Corp Ltd (9880.HK)

Q3 2026
▲2▼1

UBTECH's U1 orders surge, but US import ban clouds outlook

  • U1 humanoid orders exceed 13,000, tenfold increase UBTECH's new ultra-bionic U1 humanoid robot has received over 13,361 orders, more than ten times last year's sales. This shows strong demand for its consumer companion robot and supports future revenue growth.

    This is the main positive demand driver for UBTECH's stock, showing real product traction.

  • Humanoid robot market projected to reach $1.1 billion by 2030 TrendForce forecasts the companion robot market will hit $1.1 billion by 2030, driven by aging populations. UBTECH's U1 is well-positioned, but challenges like battery life and privacy remain.

    This validates the long-term growth potential for UBTECH's consumer robot segment.

  • US FCC bans humanoid robot imports; China threatens retaliation The US added humanoid robots to an import restriction list, citing security. China warned of countermeasures. UBTECH shares fell over 6% as the ban threatens its US market access and IPO plans.

    This is a major regulatory risk that directly impacts UBTECH's international expansion and investor sentiment.

July 2026
▲2▼1

UBTECH's U1 orders surge, but US import ban clouds outlook

  • U1 humanoid orders exceed 13,000, tenfold increase UBTECH's new ultra-bionic U1 humanoid robot has received over 13,361 orders, more than ten times last year's sales. This shows strong demand for its consumer companion robot and supports future revenue growth.

    This is the main positive demand driver for UBTECH's stock, showing real product traction.

  • Humanoid robot market projected to reach $1.1 billion by 2030 TrendForce forecasts the companion robot market will hit $1.1 billion by 2030, driven by aging populations. UBTECH's U1 is well-positioned, but challenges like battery life and privacy remain.

    This validates the long-term growth potential for UBTECH's consumer robot segment.

  • US FCC bans humanoid robot imports; China threatens retaliation The US added humanoid robots to an import restriction list, citing security. China warned of countermeasures. UBTECH shares fell over 6% as the ban threatens its US market access and IPO plans.

    This is a major regulatory risk that directly impacts UBTECH's international expansion and investor sentiment.

Latest
▲2▼1

UBTECH's U1 orders surge, but US import ban clouds outlook

  • U1 humanoid orders exceed 13,000, tenfold increase UBTECH's new ultra-bionic U1 humanoid robot has received over 13,361 orders, more than ten times last year's sales. This shows strong demand for its consumer companion robot and supports future revenue growth.

    This is the main positive demand driver for UBTECH's stock, showing real product traction.

  • Humanoid robot market projected to reach $1.1 billion by 2030 TrendForce forecasts the companion robot market will hit $1.1 billion by 2030, driven by aging populations. UBTECH's U1 is well-positioned, but challenges like battery life and privacy remain.

    This validates the long-term growth potential for UBTECH's consumer robot segment.

  • US FCC bans humanoid robot imports; China threatens retaliation The US added humanoid robots to an import restriction list, citing security. China warned of countermeasures. UBTECH shares fell over 6% as the ban threatens its US market access and IPO plans.

    This is a major regulatory risk that directly impacts UBTECH's international expansion and investor sentiment.